New Antiviral Drug Combination (Interferon and Ribavirin) for Treating Hepatitis C

Doctor's Guide -- NEW YORK -- October 14, 2010 -- For patients with the most common and difficult-to-treat form of hepatitis C virus (HCV), a new oral, direct-acting, experimental drug combination is safe and well tolerated, and shows promising antiviral activity, according to a study published early online and appearing in an upcoming edition of The Lancet.

Back to news